Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Patients’ dietary intake according to the dietary pattern. Characteristics | Overall (n = 564) | Med-LDP(n = 274) | West-LDP(n = 290) | Effect Size (95% CI) | p: Vitamin D (µg) 1 | 2.5 (1.8 to 3.6) | 2.9 (2.0 to 4.2) | 2.2 (1.5 to 3.1) | 0.695 (0.489 to 0.905) 2 | <0.001

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients aged ≥ 18 years who had been receiving thrice-weekly, 4 h, in-center HD using online hemodiafiltration for ≥15 months and who agreed to participate and provided written informed consent were included in the study.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Mediterranean-like Dietary Pattern and Serum Phosphorus in Hemodialysis: Beyond Food Phosphorus Content

Study design awaiting verification · Nutrients · 2026

Original publication title

Mediterranean-like Dietary Pattern and Serum Phosphorus in Hemodialysis: Beyond Food Phosphorus Content

Ana Valente; Inês Pastor Neto; Joana Jesus; Cristina Garagarza; Aníbal Ferreira

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In patients undergoing HD, a Mediterranean-like dietary pattern was associated with lower serum phosphorus concentrations despite a higher phosphorus intake. Additionally, this dietary pattern was not linked to increased serum potassium, and patients following this dietary pattern were able to meet the recommended protein and energy intake targets. In contrast, the Western-like dietary pattern was associated with higher serum phosphorus concentrations, although this association was no longer statistically significant after adjustment for pharmacological treatments that may impact serum phosphorus levels.

These findings support individualized dietary counseling that emphasizes phosphorus quality and overall dietary patterns rather than phosphorus restriction alone, while preserving nutritional adequacy. Further longitudinal studies are needed to evaluate the long-term impact of dietary patterns, plant-based protein intake and phosphorus bioavailability on mineral metabolism and clinical outcomes in HD patients.

Future longitudinal or interventional studies should assess the causal relationships between dietary patterns and phosphorus metabolism, considering not only phosphorus intake but also its absorption, excretion, and the use of phosphate binders. Additionally, research should explore the socioeconomic, behavioral, and educational factors that influence the adoption of healthier dietary patterns. More precise measurement tools, including phosphorus bioavailability indices and biomarkers of dietary intake, could further refine our understanding of the relationship between diet and phosphorus metabolism in patients with CKD.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Hyperphosphatemia, defined as elevated serum phosphorus concentrations, is one of the most common metabolic disturbances in patients undergoing maintenance hemodialysis (HD), affecting more than half of this population despite advances in dialysis techniques, phosphate binders, and dietary management strategies [1].

Several factors influence phosphorus homeostasis, including dietary phosphorus absorption, renal phosphate reabsorption, and the balance between bone formation and resorption [2]. As chronic kidney disease (CKD) progresses, these mechanisms become impaired, leading to vitamin D deficiency, reduced calcium absorption, and diminished renal phosphorus excretion, thereby exacerbating phosphorus and calcium imbalances. This also contributes to secondary hyperparathyroidism, stimulating bone turnover and resorption and further increasing phosphorus levels [2,3]. Consequently, hyperphosphatemia is a key component of CKD-mineral and bone disorder (CKD-MBD) and is associated with increased morbidity as it contributes to vascular calcification, bone demineralization, and cell signaling and apoptosis dysregulation, thereby increasing the risk of fractures and cardiovascular (CV) events, as well as overall and CV-related mortality [2,3].

A recent systematic review found that every 1 mg/dL increase in serum phosphorus was associated with an 18% increase in the risk of mortality [4].

The management of hyperphosphatemia is based on three fundamental pillars: dietary and lifestyle modifications, dialysis, and pharmacological treatment (including phosphate binders, active vitamin D and vitamin D analogs, and/or calcimimetics) [2]. Dietary phosphorus restriction has long been a key strategy, with older guidelines suggesting 800 to 1000 mg/day [5]. However, recent evidence suggests that phosphorus management should extend beyond total intake and consider additional nutritional factors affecting phosphorus absorption, such as the food source and matrix, the relative amounts of dietary calcium, phosphate, and vitamin D sterols, bile acid concentration, and cooking methods [5,6].

This perspective has shaped the updated KDOQI guidelines, which recommend not only adjusting dietary phosphorus intake to maintain normal serum phosphate levels but also considering the bioavailability of different phosphorus sources [5]. Animal-derived and highly processed foods containing phosphate additives have significantly higher bioavailability than plant-based sources [2,6]. Consequently, emerging literature and recent guidelines advocate reducing the consumption of ultra-processed foods with high phosphate additive content, as this may be associated with improved phosphate control [6].

There is growing recognition that assessing the overall dietary pattern may be more appropriate than focusing solely on total phosphorus intake. A Western diet: characterized by a high intake of red meat, animal fat, and highly processed foods preserved with phosphate and sodium, alongside a low intake of fresh fruits and vegetables: is estimated to provide between 1000 and 1500 mg of phosphorus per day, with 10 to 50% coming from food additives [6]. In contrast, plant-based diets may supply similar phosphorus intake, but with lower bioavailability [6,7].

These diets promote the consumption of vegetables, fruits, legumes, nuts, whole grains, and unsaturated vegetable oils while allowing the moderate consumption of animal products and limiting refined carbohydrates, sweets, and ultra-processed foods.

Furthermore, plant-based diets, including the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diets, have been associated, across diverse populations, with a reduced risk of age-related cognitive decline, dementia, Alzheimer’s disease, cardiovascular disease, and all-cause mortality [8,9,10,11,12,13].

Despite this, there is still no evidence supporting the recommendation of a specific dietary pattern to control phosphorus levels in HD patients, and few studies have focused on dietary patterns in this population. This raises a key question: could Western diets increase the risk of hyperphosphatemia, while plant-based diets: widely linked to better health outcomes: be associated with better maintenance of phosphorus balance in HD patients? Therefore, this study aimed to explore whether adopting a Mediterranean-like dietary pattern (Med-LDP), compared with a Western-like dietary pattern (West-LDP) was associated with lower serum phosphorus levels.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Study Design and Subjects

This was a cross-sectional, multicenter, observational study that included 564 patients undergoing maintenance HD at 37 dialysis centers in Portugal.

Patients aged ≥ 18 years who had been receiving thrice-weekly, 4 h, in-center HD using online hemodiafiltration for ≥15 months and who agreed to participate and provided written informed consent were included in the study. The minimum HD vintage of 15 months was defined considering that the Food Frequency Questionnaire (FFQ) assesses dietary habits during the 12 months preceding its administration, in addition to the usual 3-months period defined in most HD studies, which is considered as an adaptation period to treatment and dietary recommendations.

The exclusion criteria were: limited understanding of Portuguese, severe neurological or mental disorders, active neoplastic disease, major amputation (lower/upper extremities), enteral or parenteral feeding, severe alcohol or drug addiction, hepatitis C with viral replication, liver disease, and treatment with immunosuppressive agents or corticosteroids.

Among the 4600 patients undergoing HD across 37 dialysis centers, 600 patients meeting the eligibility criteria were randomly selected in equal proportions from each center. Of these, 18 patients (3%) declined to participate, resulting in a study population of 582 patients. Among the enrolled participants, 564 had available pre-dialysis serum phosphorus measurements and were therefore included in the final study population.

Patients underwent post-dilution online hemodiafiltration using high-flux polysulfone membranes (Helixone®; Fresenius Medical Care®, Bad Homburg, Germany) and ultrapure water that met the requirements of the International Organization for Standardization (ISO) 13959:2009 standard for water used in hemodialysis and related therapies.

2.2. Data Analysis

Demographic, anthropometric, body composition, biochemical parameters as well as dialysis treatment data were collected from the patients’ clinical records during the same month in which the FFQ was administered.

2.3. Anthropometric and Body Composition Analysis

Body composition was assessed using bioimpedance spectroscopy with the Body Composition Monitor (BCM) (version 3.3, Fresenius Medical Care® Deutschland GmbH, Bad Homburg, Germany) which has been validated against the gold standard reference methods in several studies involving more than 500 patients and healthy controls [14,15,16,17]. The measurements had a quality index greater than 95%. This evaluation was performed with the patient lying supine, approximately 30 min before the midweek HD sessions, with four conventional electrodes (Fresenius Medical Care): two placed on the hand and two on the foot contralateral to the vascular access.

To ensure measurement quality, only measurements with a quality indicator above 90% were accepted. This quality indicator is provided by the BCM, which performs measurements at 50 frequencies ranging from 5 to 1000 kHz. The body composition analysis included the lean tissue index (LTI), fat tissue index (FTI), body cell mass index (BCMI), fat mass (%), lean tissue mass (%), intracellular water (l), extracellular water (l), and relative overhydration (%) (pre-dialysis overhydration/extracellular water [OH/ECW]).

2.4. Dietary Intake

Dietary intake was assessed using a semi-quantitative FFQ, developed and validated for the Portuguese population [18,19]. The questionnaire was administered by a registered dietitian in a face-to-face interview while the patient was undergoing HD treatment. The FFQ included 95 food items, a section with predetermined average portion sizes, and nine intake-frequency categories ranging from “never or less than once a month” to “six or more times a day”. Patients were asked to describe their dietary habits during the previous 12 months, specifically the frequency of consumption and the mean portion size of each food item.

A booklet containing 131 color photos illustrating food servings was used as a visual aid.

Dietary intake was then estimated by multiplying the consumption frequency of each item by its respective portion size (in grams), and a seasonal factor variation factor. Information on daily intake of macro: and micronutrients was extracted from this questionnaire using Food Processor Plus software (version 11.7.217; ESHA Research, Salem, OR, USA), which contains nutritional data from the United States Department of Agriculture. The database was supplemented with information on nutrient content of Portuguese foods obtained from the Portuguese food composition table [20].

Before statistical analysis, all food items with a mean intake of ≤5 g/day were excluded using an investigator-defined operational threshold, consistent with our previously published methodology [21], to reduce the number of variables representing foods with very low average consumption in the study population.

Twenty-two food groups were created based on similar nutritional characteristics: dairy products; eggs; white meat; red meat; fish; white bread, rice, pasta and potatoes; whole grain bread; vegetables; fruit; vegetable soup; chicken soup and Portuguese green soup; legumes; nuts; olives and olive oil; oils; fried and savory snacks; fast food; bakery products; alcoholic beverages; caffeinated drinks; barley drinks; and soft drinks. Each food group was adjusted for total energy intake and used to define dietary patterns in this population. The patterns were named according to the food groups with the highest factor loadings.

2.5. Laboratory Variables

The biochemical parameters of the overall population were assessed and compared between the dietary pattern groups, including sodium, potassium, phosphorus, calcium, calcium/phosphorus product (Ca/P), intact parathyroid hormone (PTHi), normalized protein catabolic rate (nPCR), albumin, ferritin and hemoglobin. Blood samples used for biochemical analysis were collected before the midweek HD session.

Serum sodium and potassium concentrations were determined by indirect potentiometry, whereas phosphorus and calcium concentrations were assessed using the UV molybdate and o-cresolphthalein colorimetric methods, respectively. iPTH and ferritin concentrations were quantified by chemiluminescent immunoassay (CLIA). Hemoglobin was measured by spectrophotometry in whole blood, and serum albumin was determined using the bromocresol green method. All laboratory parameters were measured using identical methods across the different laboratories.

2.6. Statistical Analysis

Dietary patterns were derived from principal component analysis (PCA) based on 22 food groups. PCA with varimax rotation and Kaiser normalization was applied to improve the interpretability of the factors. The number of dietary patterns retained was determined based on eigenvalues > 1.5 (which indicate the total variance explained by a given factor), as well as the scree plot examination, and the interpretability of the derived patterns. Adherence to each dietary pattern was then determined using the factor scores generated by the PCA, and participants were assigned to the dietary pattern for which they had the highest factor score.

This approach was chosen because the aim of the study was to characterize the predominant dietary patterns within the study population and compare the clinical characteristics of participants according to their predominant dietary profile.

Data distribution was evaluated using the Kolmogorov: Smirnov test. Normally distributed continuous variables were expressed as the mean (standard deviation [SD]), whereas median (interquartile range [IQR]) was used for non-normally distributed continuous variables. Categorical variables were presented as frequencies and percentages. Pearson’s chi-squared test was used to analyze categorical variables. Differences between groups were evaluated using the independent samples t-test for normally distributed variables, and the Mann: Whitney test for non-normally distributed variables. To complement p-values, effect sizes and their 95% confidence intervals (95% CIs) were reported.

Hedges’ g was used for independent samples t-tests, Hodges: Lehmann estimates of median differences were used for the Mann: Whitney test, and odds ratios (ORs) and Cramer’s V were used for categorical variables with two and more than two categories, respectively. Confidence intervals for Cramer’s V were estimated using bias-corrected and accelerated (BCa) bootstrap methods. Spearman’s correlation tests, and linear regression analyses were performed to evaluate the associations of dietary phosphorus intake, phosphorus/protein ratio, and dietary patterns with serum phosphorus levels.

The multivariate analyses was adjusted for age, sex, presence of diabetes mellitus, energy intake, phosphorus/protein intake ratio, dialysis adequacy, HD vintage, vascular access, PTHi, albumin, residual diuresis (patient-reported), and the prescribed weekly doses of phosphorus binders (calcium acetate/magnesium carbonate, sevelamer carbonate, and sucroferric oxyhydroxide), calcimimetics (cinacalcet), and vitamin D supplementation and analogs (alfacalcidol, paricalcitol, and calcitriol). All statistical analyses were performed using the IBM SPSS Statistics software (version 29.0; IBM Corp., Armonk, NY, USA), and a p-value < 0.05 was considered statistically significant.

Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods

Discussion

In this study, no association between phosphorus intake and serum phosphorus levels was found. In addition, two distinct dietary patterns characterizing this population were identified: the Med-LDP (48.6%) and the West-LDP (51.4%): and the West-LDP was found to be associated with significantly higher serum phosphorus levels, independent of total phosphorus intake. In contrast, the Med-LDP, despite being richer in total phosphorus and protein, was linked to lower serum phosphorus and PTHi levels and a lower calcium: phosphorus product.

Patients following the Med-LDP tended to be older, which may reflect a stronger cultural influence of this diet among older generations, as well as greater health awareness or adherence to dietary recommendations. In contrast, the West-LDP was associated with younger age, which may reflect poorer dietary habits influenced by the dietary westernization, characterized by a higher consumption of inexpensive and ultra-processed foods rich in phosphate additives.

A higher prevalence of DM, as well as a higher age-adjusted comorbidity score was observed in the Med-LDP group. One possible explanation is that patients diagnosed with DM or other clinical conditions (such as cardiovascular diseases, dementia, cancer, etc.) [22] may be more likely to receive dietary counseling and therefore adopt healthier eating habits, including a mediterranean diet. This dietary pattern is widely promoted because of its potential benefits for glycemic control and cardiovascular health [23,24,25,26].

Regarding dietary intake, individuals following the Med-LDP demonstrated higher intakes of energy, protein, dietary fiber, and multiple micronutrients, including phosphorus and potassium. Despite these higher intakes, they exhibited lower serum phosphorus and iPTH level and lower calcium: phosphorus product, while no differences were found in serum potassium, calcium, or sodium levels. These findings suggest that patients following the Med-LDP had a more favorable biochemical profile despite their higher phosphorus and protein intake. This interpretation is further supported by Carrero J. et al. and Garagarza C. et al. [21,27], who observed that patients following a healthy plant-based diet did not have higher serum potassium levels and that greater adherence to the DASH diet was associated with lower serum potassium levels, despite the diet’s naturally higher potassium content.

This highlights the importance of the overall dietary quality rather than focusing solely on the absolute intake of single nutrients. However, our observations may also be influenced by differences in baseline clinical characteristics between the groups, including age, comorbidity burden, nutritional status, and residual kidney function. A higher proportion of patients following the Med-LDP had a residual urine output > 200 mL/day, which may have contributed to lower serum phosphorus through preserved residual phosphorus excretion. Nevertheless, residual urine output was included as a confounding factor in the multivariable analysis, and adherence to the Western-like dietary pattern remained independently associated with higher serum phosphorus levels.

In the context of dialysis, protein and energy intake should also be considered, as nutritional adequacy is essential to prevent protein: energy wasting and promote favorable outcomes. In our study, patients following the Med-LDP had higher energy and protein intakes than those adhering to a West-LDP. However, it is worth emphasizing that these intakes remained within the KDOQI-recommended ranges for energy and protein per kilogram of body weight [5]. Importantly, despite the lower nPCR and serum albumin levels observed in the Med-LDP group, both remained within the clinically recommended ranges, supporting the nutritional adequacy and safety of this dietary pattern in patients undergoing HD.

Furthermore, no differences in dialysis access or adequacy were observed, suggesting that these factors: known to influence several serum biomarkers, including serum phosphorus: were unlikely to explain the lack of a positive association with phosphorus intake.

The phosphorus-to-protein ratio was inversely associated with serum phosphorus levels in both dietary groups, with a stronger and statistically significant correlation observed in the Med-LDP (ρ = −0.167; p = 0.005). In contrast, the association was weaker and not statistically significant in the West-LDP group (ρ = −0.091; p = 0.120). Noori et al. reported that higher dietary phosphorus-to-protein ratios were associated with increased mortality risk in patients receiving maintenance HD, supporting the clinical rationale for selecting protein sources with a lower phosphorus burden per gram of protein [28,29].

However, the phosphorus-to-protein ratio does not account for differences in phosphorus bioavailability between food sources. While a lower ratio is generally considered advantageous because it identifies foods that provide less phosphorus per gram of protein, this concept assumes comparable intestinal phosphorus absorption regardless of the food source. In the Mediterranean diet, however, a substantial proportion of phosphorus is derived from plant-based foods such as legumes, nuts, and whole grains, in which phosphorus is largely bound to phytates and therefore less available for intestinal absorption.

Consequently, higher phosphorus-to-protein ratios within this dietary pattern may not necessarily result in a greater absorbed phosphorus load, potentially explaining the inverse association observed.

Interestingly, despite the higher total phosphorus intake in the Med-LDP group, serum phosphorus levels remained lower, and no significant association was observed between dietary phosphorus intake and serum phosphorus concentrations. This finding is consistent with that of Noori et al., who also reported a weak correlation between phosphorus intake and serum phosphorus levels [28]. Conversely, a significant positive correlation between dietary phosphorus intake and serum phosphorus levels was observed in the West-LDP (ρ = 0.171, p = 0.004).

Taken together, these findings suggest that the relationship between dietary phosphorus intake and serum phosphorus levels may depend not only on the quantity consumed but also on the predominant food sources of dietary phosphorus.

The contrasting associations observed between the dietary patterns further support the concept that the clinical interpretation of the phosphorus-to-protein ratio should consider the overall dietary pattern. Since dietary patterns capture the combined effects of multiple foods and nutrients rather than isolated dietary components, the inverse correlation observed in the Med-LDP group may be related to the overall dietary matrix.

As emphasized by St-Jules et al. and Byrne et al., dietary phosphorus management in CKD should consider not only the phosphorus-to-protein ratio but also the phosphorus source, bioavailability, phosphate additives, and the broader food matrix [30,31]. This is particularly relevant to Western dietary patterns, in which processed and ultra-processed foods contribute substantially to phosphorus intake through highly bioavailable phosphate additives. In fact, phosphate additive intake potentially accounts for between 10% and 50% of total phosphorus intake.

These additives are widely used in processed and ultra-processed foods, including processed meats, fast food, bakery products, and soft drinks, particularly cola beverages, thereby increasing the intake of highly bioavailable phosphorus, which may not be fully captured by conventional dietary assessment methods [6,29].

The West-LDP was also found to be an independent predictor of higher serum phosphorus levels. Overall, these findings suggest that dietary patterns may be a more relevant determinant of serum phosphorus levels than either total phosphorus intake or the phosphorus-to-protein ratio considered in isolation This association may be partly explained by differences in food sources and phosphorus bioavailability. This challenges the traditional phosphorus-restriction model, which often discourages the consumption of nutrient-dense, phosphorus-rich foods such as legumes and whole grains, and instead supports a more nuanced approach that prioritizes food quality, bioavailability, and the overall dietary context.

Accordingly, current guidelines emphasize the individualization of dietary management rather than rigid phosphorus restriction [5]. However, this predictive effect was lost when the model was adjusted for the prescribed dose of phosphorus binders, calcimimetics, and vitamin D supplements and analogs. This may reflect a greater influence of these agents on control serum phosphorus in the context of diets with a high phosphorus content.

Nevertheless, from a clinical perspective, dietary counseling, as one of the cornerstone approaches to control hyperphosphatemia and CKD-MBD in HD patients [2], should extend beyond phosphorus counting and focus on educating patients about phosphorus sources and dietary patterns that may support mineral balance while maintaining nutritional adequacy, as previously demonstrated by Fornasari et al. and Sullivan et al. [32,33]. Further studies are warranted to examine the long-term effects of phosphorus quality and the phosphorus-to-protein ratios on mineral metabolism and health outcomes.

The cross-sectional design of this study can be considered as a limitation because it does not allow causal relationships to be established. The use of a food frequency questionnaire is subject to recall bias and may lead to errors in the estimation of dietary intake. The dietary patterns identified in this study were empirically derived using PCA in a Portuguese cohort and do not represent validated measures of adherence to the Mediterranean or Western diets. Furthermore, the phosphorus content of foods, especially processed foods, can be highly variable and is not consistently documented in nutrient databases, potentially leading to the underestimation or overestimation of intake.

The strengths of this study include its large multicenter sample comprising 564 HD patients from 37 dialysis units which increased the statistical power and supports the generalizability of the findings. Furthermore, the study simultaneously evaluated dietary intake, dietary patterns, mineral metabolism biomarkers, nutritional parameters, and dialysis-related variables, allowing for a comprehensive assessment of phosphorus homeostasis. This included the evaluation of total phosphorus intake, the phosphorus-to-protein ratio, and dietary patterns, providing a broader assessment of dietary phosphorus than would be achieved by assessing isolated nutrients alone.

By adopting a dietary pattern approach that reflects real-world eating behaviors, this study provides clinically relevant insights that are aligned with current guideline recommendations and may enhance the translational value of the findings in routine clinical practice.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

Two different dietary patterns were identified (Table 1): a Med-LDP characterized by a higher intake of vegetables (109 ± 99 g/day), legumes (22 ± 30 g/day), fruit (314 ± 217 g/day), starchy products (278 ± 190 g/day), fish (69 ± 46 g/day), olive oil [14 ± 15 g/day), eggs (22 ± 23 g/day), bakery products (56 ± 72 g/day), and alcohol (95 ± 155 mL/day); and a West-LDP characterized by higher intake of soft drinks (70 ± 121 mL/day), red meat (71 ± 188 g/day), fried and savory snacks (13 ± 18 g/day), fast food (7 ± 14 g/day), and caffeinated drinks (107 ± 113 mL/day) (Table 2).

The median age of the overall population was 71 years (IQR: 61 to 78), with a median HD vintage of 65 months (IQR: 43 to 105). Male participants accounted for 41.3% of the cohort, while 31.4% had diabetes mellitus (DM). Regarding vascular access for hemodialysis, 83% of patients used arteriovenous fistulas (Table 3). Median serum phosphorus differed between the dietary patterns, with the patients following a West-LDP having higher serum phosphorus levels (Figure 1). The characteristics of the overall population, as well as differences in demographic, body composition, biochemical, and dialysis-related parameters between patients following a Med-LDP and those following a West-LDP, are presented in Table 3.

Regarding phosphate binder prescriptions, 26.6%, 3.55% and 17.38% of the overall population were prescribed calcium acetate/magnesium carbonate, sucroferric oxyhydroxide, and sevelamer carbonate, respectively. Only sevelamer carbonate prescription differed significantly between dietary patterns (p = 0.001), with 33 patients (12.04%) in the Med-LDP and 65 (22.41%) in the West-LDP group receiving this phosphate binder.

Despite the higher intakes of protein, carbohydrates, calories, fat, phosphorus, and potassium in the Med-LDP group, serum phosphorus levels, nPCR, Ca/P product, and PTHi were significantly lower (p < 0.05). Patients in the Med-LDP group also had significantly higher intakes of fiber, vitamins (A, B complex, C, D, E, K), and minerals (including calcium, iron, magnesium, manganese, phosphorus, potassium, sodium, zinc, and selenium) (Table 4). However, no statistically significant differences were observed between the two groups in serum of potassium, ferritin, hemoglobin, calcium, and sodium (p > 0.05) (Table 3).

Although a positive correlation between dietary phosphorus intake and serum phosphorus was observed in both groups, the correlation was stronger and statistically significant only in the West-LDP group (ρ = 0.171; p = 0.004), whereas it did not reach statistical significance in the Med-LDP group (ρ = 0.114; p = 0.059) (Figure 2). In contrast, the phosphorus-to-protein ratio was negatively correlated with serum phosphorus levels in both dietary patterns. The correlation was stronger and statistically significant in the Med-LDP group (ρ =: 0.167; p = 0.005), whereas it was weaker and not statistically significant in the West-LDP group (ρ =: 0.091; p = 0.120) (Figure 3).

In addition, the West-LDP was an independent predictor of higher serum phosphorus levels (p < 0.001). After adjustment for potential confounders, the West-LDP remained a predictor of higher serum phosphorus levels (p = 0.027). However, this association was no longer statistically significant after further adjustment for the prescribed doses of phosphorus binders, calcimimetics, and vitamin D supplementation and analogs (p = 0.060) (Table 5).

Table 1

Factor loadings for two dietary patterns derived by Principal Components Analysis. Data expressed as factor loading (correlation coefficient between each food group and dietary pattern). Food groups with factor loadings ≥ 0.3 were bolded to indicate the main food groups in each component.

Food GroupsComponents
Med-LDPWest-LDP
Dairy products0.2360.008
White meat0.2770.206
Red meat0.224 0.538
Olives and olive oil 0.399 0.328
Oils0.1440.241
White bread, rice, pasta and potatoes 0.316 0.136
Eggs 0.353 0.164
Fried and savory snacks0.260 0.555
Bakery products 0.328 0.272
Alcoholic beverages 0.388 0.064
Caffeinated drinks0.062 0.358
Fast food0.017 0.686
Vegetable soup0.237−0.261
Chicken soup and Portuguese green soup0.188−0.094
Barley drinks0.221−0.171
Vegetables 0.649 0.112
Fruit 0.630 −0.001
Whole grain bread0.051−0.126
Soft drinks−0.060 0.697
Legumes 0.550 0.100
Nuts0.0420.151
Fish 0.578 0.016
Table 2

Food consumption according to the dietary pattern.

CharacteristicsMed-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size
(95% CI)
p
Dairy products (g/day) 1250 ± 229174 ± 1760.375 (0.208 to 0.541) 2<0.001
White meat (g/day) 138 ± 3633 ± 300.149 (−0.016 to 0.314) 20.077
Red meat (g/day) 155 ± 6871 ± 188−0.115 (−0.279 to 0.051) 20.165
Fish (g/day) 169 ± 4641 ± 290.712 (0.541 to 0.881) 2<0.001
Eggs (g/day) 122 ± 2315 ± 170.333 (0.167 to 0.499) 2<0.001
Olives and olive oil (g/day) 114 ± 1510 ± 130.242 (0.076 to 0.407) 20.004
Oils (g/day) 15 ± 66 ± 7−0.084 (−0.249 to 0.081) 20.318
White bread, rice, pasta and potatoes (g/day) 1278 ± 190235 ± 1320.260 (0.094 to 0.426) 20.002
Whole grain bread (g/day) 186 ± 11461 ± 880.244 (0.078 to 0.409) 20.004
Vegetables (g/day) 1109 ± 9961 ± 590.589 (0.420 to 0.757) 2<0.001
Fruit (g/day) 1314 ± 217168 ± 1070.850 (0.677 to 1.022) 2<0.001
Legumes (g/day) 122 ± 3012 ± 160.431 (0.264 to 0.598) 2<0.001
Nuts (g/day) 12 ± 63 ± 1−0.074 (−0.239 to 0.091) 20.380
Vegetable soup (mL/day) 1150 ± 16648 ± 690.810 (0.638 to 0.981) 2<0.001
Chicken soup and Portuguese green soup (mL/day) 18 ± 262 ± 100.318 (0.152 to 0.484) 2<0.001
Fried and savory snacks (g/day) 111 ± 1513 ± 18−0.102 (−267 to 0.063) 20.224
Bakery products (g/day) 156 ± 7252 ± 520.062 (−0.103 to 0.227) 20.459
Alcoholic beverages (mL/day) 195 ± 15552 ± 1160.315 (0.149 to 0.480) 2<0.001
Caffeinated drinks (mL/day) 187 ± 83107 ± 113−0.196 (−0.361: (−0.0311)) 20.020
Barley drinks (mL/day) 147 ± 1165 ± 250.511 (0.343 to 0.679) 2<0.001
Soft drinks (mL/day) 118 ± 4170 ± 121−0.575 (−0.743: (−0.406)) 2<0.001
Fast Food (g/day) 12 ± 47 ± 14−0.442 (−0.609: (−0.275)) 2<0.001

1 Mean ± Standard Deviation; 2 Hodges: Lehmann differences and 95% CI.

Table 3

Patients’ characteristics according to the dietary pattern.

CharacteristicsOverall
(n = 564)
Med-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size (95% CI) p
Demographics
Age (years) 271 (61 to 78)73 (65 to 80)69 (54 to 76)5 (3 to 7) 3<0.001
Male (%)233 (41.3%)107 (39.1%)126 (43.4%)0.834 (0.596 to 1.167) 40.289
Diabetes mellitus (%)177 (31.4%)100 (36.5%)77 (26.6%)1.590 (1.111 to 2.275) 40.011
Age-Adjusted Charlson Index (score)6 (4 to 7)6 (5 to 8)5 (4 to 7)1 (1 to 1) 3<0.001
Dialysis characteristics
Hemodialysis vintage (months) 265 (43 to 104.8)62 (41 to 99)69 (43 to 112)−6 (−12 to 0) 30.034
Arteriovenous fistula (%)468 (83.0%)229 (83.6%)239 (82.4%)0.058 (0.003 to 0.183) 50.392
Catheter (%)36 (6.4%)20 (7.3%)16 (5.5%)
Arteriovenous grafts (%)60 (10.6%)25 (9.1%)35 (12.1%)
Kt/V: dialysis adequacy 21.70 (1.50 to 1.90)1.70 (1.49 to 1.92)1.71 (1.52 to 1.87)0.01(−0.06 to 0.07) 30.884
OH/ECW pre (%) 27.3 (2.7 to 11.88)7.5 (3.2 to 11.9)7.1 (2.2 to 11.7)0.7 (−0.6 to 1.9) 30.317
Intracellular water (L) 117.37 ± 3.7916.99 ± 3.6217.72 ± 3.91−0192 (−0.366: (−0.018)) 60.031
Extracellular water (L) 216.3 (14.5 to 18.3)16.3 (14.6 to 18.6)16.0 (14.4 to 18.2)−0.2 (−0.3 to 0) 30.321
Intradialytic weight gain (%) 23.1 (2.3 to 4.0)2.9 (2.2 to 4.0)3.3 (2.3 to 4.2)−0.2 (−0.4 to 0) 30.079
Residual diuresis > 200 mL (%)333 (59.3%)175 (64.3%)158 (54.5%)1.507 (1.074 to 2.116) 40.017
Body Composition
BMI (kg/m2) 225.8 (22.6 to 29.0)26.0 (23.2 to 29.8)25.4 (22.3 to 28.8)0.71 (−0.08 to 1.5) 30.079
Lean Tissue Mass (%) 246.9 (38.7 to 56.1)45.4 (37.6 to 52.9)49.3 (40.8 to 60.1)−4.2 (−6.6: (−1.9)) 3<0.001
Lean Tissue Index (kg/m2) 212.2 (10.7 to 14.2)12 (10.4 to 13.5)12.6 (10.9 to 14.5)−0.7 (−1.1: (−0.2)) 30.005
Body Cell Mass Index (kg/m2) 210.7 (8.8 to 13.2)10.2 (8.3 to 12.4)11.2 (9.0 to 13.8)−0.831 (−1.421: (−0.257)) 30.005
Fat Mass (%) 236.8 (29.8 to 42.9)37.6 (32.9 to 43.5)35.2 (27.5 to 41.6)2.8 (1.1 to 4.6) 30.001
Fat Tissue Index (kg/m2) 213.0 (9.4 to 16.9)13.9 (10.7 to 17.2)12.2 (8.4 to 16.3)1.5 (0.5 to 2.4) 30.003
Biochemical Parameters
nPCR (g/kg/day) 21.1 (1.0 to 1.3)1.1 (1.0 to 1.3)1.2 (1.1 to 1.3)−0.07 (−0.120: (−0.020)) 30.008
Sodium (mEq/L) 2139 (138 to 141)139 (137 to 141)140 (138 to 141)0 (−1.0 to 0) 30.061
Potassium (mEq/L) 15.3 ± 0.75.3 ± 0.75.3 ± 0.7−0.025 (−0.193 to 0.143) 60.948
Phosphorus (mg/dL) 24.2 (3.5 to 5.0)3.9 (3.3 to 4.8)4.4 (3.6 to 5.2)−0.4 (−0.6: (−0.2)) 3<0.001
Calcium (mg/dL) 28.9 (8.5 to 9.4)8.9 (8.6 to 9.3)8.9 (8.5 to 9.5)0 (−0.1 to 0.1) 30.925
Calcium/Phosphorus product [(mg/dL)2] 237.3 (30.7 to 46.1)35.0 (29.2 to 44.9)39.4 (32.7 to 47.1)−3.43 (−5.24: (−1.62)) 3<0.001
PTHi (ng/L) 2352 (211 to 573)297 (183 to 496)399 (232 to 618.5)−80 (−122: (−38)) 3<0.001
Albumin (g/dL) 24.05 (3.9 to 4.2)4 (3.8 to 4.2)4.1 (3.9 to 4.3)−0.1 (−0.13: (−0.03)) 3<0.001
Ferritin (µg/L) 2455 (329 to 611)455(328 to 620)455 (329 to 602)1.1 (−35.9 to 37.8) 30.957
Hemoglobin (g/dL) 211.2 (10.6 to 11.9)11.2 (10.7 to 11.9)11.2 (10.6 to 11.8)0.1 (−0.1 to 0.2) 30.342
Phosphorus Binders
weekly prescription (mg)
Calcium acetate/magnesium 12801 ± 59572491 ± 55743093 ± 6293−0.101 (−0.266 to 0.100) 60.232
Sevelamer carbonate 12636 ± 72411574 ± 50433640 ± 8720−0.288 (−0.453: (−0.122)) 6<0.001
Sucroferric oxyhydroxide 1183 ± 1274141 ± 1171223 ± 13660.065 (−0.453: (−0.122)) 60.442

1 Mean ± SD; 2 Median (IQR); 3 Hedges’ g and 95% CI; 4 Odds Ratio and 95% CI; 5 Cramer’s V and 95% CI; 6 Hodges: Lehmann differences and 95% CI; TEI: Total Energy Intake.

Table 4

Patients’ dietary intake according to the dietary pattern.

CharacteristicsOverall (n = 564)Med-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size (95% CI) p
Energy (kcal) 11808 (1449 to 2298)2025 (1654 to 2515)1618 (1285 to 2032)407 (304 to 509) 2<0.001
Energy (kcal/kg) 126.4 (20.4 to 33.5)29.2 (23.3 to 36.6)24.1 (17.1 to 30.3)5.45 (3.838 to 7.060) 2<0.001
Protein (g) 175.4 (58.6 to 98.8)84.4 (68.3 to 107.8)68.2 (50.0 to 87.4)18.086 (13.528 to 22.520) 2<0.001
Protein (g/kg) 11.1 (0.9 to 1.4)1.2 (1.0 to 1.6)1.0 (0.7 to 1.3)0.240 (0.173 to 0.309) 2<0.001
Carbohydrates (g) 1240 (184 to 294)266 (222 to 331)213 (169 to 266)54.986 (41.552 to 68.505) 2<0.001
Complex carbohydrates (g) 174.5 (56.9 to 104.8)83.0 (63.7 to 115.8)66.6 (51.6 to 95.1)15.421 (10.225 to 20.841) 2<0.001
Sugar (g) 169.3 (50.1 to 95.0)77.3 (62.1 to 110.1)60.4 (43.9 to 83.8)19.751 (14.616 to 24.722) 2<0.001
Total fat (g) 157.1 (44.1 to 77.6)63.4 (49.4 to 81.1)50.3 (40.1 to 71.0)10.609 (6.937 to 14.308) 2<0.001
Saturated fat (g) 117.4 (13.2 to 24.0)19.0 (14.7 to 25.0)15.6 (12.5 to 23.3)2.501 (1.271 to 3.737) 2<0.001
Monounsaturated fat (g) 124.7 (18.8 to 34.0)27.8 (21.6 to 35.4)21.7 (17.0 to 30.4)4.983 (3.371 to 6.629) 2<0.001
Polyunsaturated fat (g) 19.6 (7.2 to 12.5)10.6 (8.3 to 13.4)8.4 (6.5 to 11.3)1.831 (1.231 to 2.431) 2<0.001
Cholesterol (mg) 1243 (161 to 332)280 (199 to 348)208 (142 to 281)59.724 (40.996 to 78.497) 2<0.001
Protein (% TEI) 116.7 (15.3 to 18.7)16.8 (15.3 to 18.7)16.6 (15.3 to 18.7)0.154 (−0.272 to 0.583) 20.479
Carbohydrates (% TEI) 153.1 (47.7 to 57.0)53.4 (48.6 to 57.0)52.8 (46.7 to 57.0)0.400 (−0.792 to 1.600) 20.529
Fat (% TEI) 129.2 (25.7 to 32.6)28.5 (25.3 to 32.0)30 (26.2 to 33.8)−1.328 (−2.232: (−0.434)) 20.003
Dietary fiber (g) 119.1 (14.4 to 25.9)23.2 (18.1 to 30.2)16.0 (12.4 to 20.9)7.081 (5.856 to 8.363) 2<0.001
Caffeine (mg) 158.4 (25.7 to 81.3)38 (16.0 to 79.8)78.8 (31.5 to 85.9)−9.502 (−16.312: (−2.461)) 2<0.001
Vitamin B6 (mg) 11.4 (1.0 to 1.7)1.5 (1.3 to 1.9)1.1 (0.9 to 1.5)0.416 (0.339 to 0.495) 2<0.001
Vitamin B12 (µg) 15.0 (3.3 to 7.4)6.0 (3.8 to 8.1)4.2 (2.7 to 6.6)1.473 (0.997 to 1.964) 2<0.001
Folate (µg) 1206 (156 to 275)239 (191 to 317)178 (136 to 233)67.744 (51.328 to 78.667) 2<0.001
Vitamin C (mg) 165.2 (45.3 to 98.2)81.8 (58.7 to 117.06)52.5 (36.7 to 76.4)29.386 (23.892 to 35.271) 2<0.001
Vitamin D (µg) 12.5 (1.8 to 3.6)2.9 (2.0 to 4.2)2.2 (1.5 to 3.1)0.695 (0.489 to 0.905) 2<0.001
Calcium (mg) 1666 (461 to 894)769 (557 to 1024)555 (395 to 784)196.130 (145.102 to 249.273) 2<0.001
Iron (mg) 113.3 (10.7 to 16.6)14.7 (12.2 to 18.8)12.0 (9.4 to 15.0)3.044 (2.277 to 3.809) 2<0.001
Magnesium (mg) 1243 (191 to 322)287 (227 to 366)212 (161 to 268)78.334 (60.749 to 90.256) 2<0.001
Phosphorus (mg) 11068 (814 to 1385)1206 (941 to 1559)954 (701 to 1213)278.921 (211.719 to 346.389) 2<0.001
Phosphorus/protein ratio (mg/g) 114.0 (12.7 to 15.4)14.3 (12.8 to 15.6)13.7 (12.5 to 15.3)0.433 (0.102 to 0.751) 20.010
Potassium (mg) 12320 (1791 to 2946)2661 (2218 to 3352)1970(1481 to 2462)762.992 (630.765 to 892.511) 2<0.001
Selenium (µg) 191.3 (67.8 to 139.7)108.2 (79.1 to 158.6)78.8 (62.1 to 116.4)26.906 (19.728 to 34.289) 2<0.001
Sodium (mg) 12196 (1634 to 2825)2456 (1837 to 2998)1972 (1464 to 2534)448.257 (312.820 to 583.106) 2<0.001
Zinc (mg) 18.8 (6.7 to 11.6)9.9 (7.6 to 13.1)7.9 (5.8 to 10.4)2.055 (1.499 to 2.591) 2<0.001

1 Median (IQR); 2 Hodges: Lehmann differences and 95% CI; TEI: Total Energy Intake.

Table 5

Linear Regression Analysis Between Serum Phosphorus and Dietary Pattern.

Dependent VariableIndependent VariableB (95% CI)
(n = 564)
p B a (95% CI)
(n = 355)
p B b (95% CI)
(n = 352)
p
Serum phosphorusDietary Pattern (West-LDP;
Indicator: Med-LDP)
0.35 (0.16 to 0.54)<0.0010.29 (0.03 to 0.54)0.0270.24 (−0.01 to 0.49)0.060

a Adjusted for: age, gender, DM, dialysis vintage, PTHi, dialysis dose (Kt/V), pre-dialysis albumin, energy (kcal), phosphorus/protein ratio, vascular access, residual diuresis > 200 mL. b Adjusted for: age, gender, DM, dialysis vintage, PTHi, dialysis dose (Kt/V), pre-dialysis albumin, energy (kcal), phosphorus/protein ratio, vascular access, residual diuresis > 200 mL, weekly prescription of phosphorus binders, calcimimetics, and vitamin D supplementation and analogs.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusions

In patients undergoing HD, a Mediterranean-like dietary pattern was associated with lower serum phosphorus concentrations despite a higher phosphorus intake. Additionally, this dietary pattern was not linked to increased serum potassium, and patients following this dietary pattern were able to meet the recommended protein and energy intake targets. In contrast, the Western-like dietary pattern was associated with higher serum phosphorus concentrations, although this association was no longer statistically significant after adjustment for pharmacological treatments that may impact serum phosphorus levels.

These findings support individualized dietary counseling that emphasizes phosphorus quality and overall dietary patterns rather than phosphorus restriction alone, while preserving nutritional adequacy. Further longitudinal studies are needed to evaluate the long-term impact of dietary patterns, plant-based protein intake and phosphorus bioavailability on mineral metabolism and clinical outcomes in HD patients.

Future longitudinal or interventional studies should assess the causal relationships between dietary patterns and phosphorus metabolism, considering not only phosphorus intake but also its absorption, excretion, and the use of phosphate binders. Additionally, research should explore the socioeconomic, behavioral, and educational factors that influence the adoption of healthier dietary patterns. More precise measurement tools, including phosphorus bioavailability indices and biomarkers of dietary intake, could further refine our understanding of the relationship between diet and phosphorus metabolism in patients with CKD.

Source: 5. Conclusions Source: 5. Conclusions Source: 5. Conclusions
Authors’ abstract

Background: Disturbances in mineral and bone metabolism are common in hemodialysis (HD) patients, increasing the risk of hyperphosphatemia. Dietary phosphorus restriction remains a cornerstone of management, often leading to stringent dietary recommendations. This study aimed to explore whether adopting a Mediterranean-like dietary pattern (Med-LDP), compared to a Western-like dietary pattern (West-LDP) was associated with serum phosphorus levels. Methods: This cross-sectional multicenter study included 564 HD patients from 37 dialysis centers. Dietary intake was assessed using a food frequency questionnaire, and dietary patterns were identified through principal component analysis based on 22 food groups.

Associations between dietary patterns, phosphorus intake, and serum phosphorus levels were evaluated using correlations tests and linear regression analyses adjusted for demographic, clinical, nutritional, and dialysis-related factors. Results: Two different dietary patterns were identified: a “Mediterranean-like” pattern characterized by a higher intake of vegetables, legumes, fruit, starchy products, fish, olive oil, eggs, bakery products, and alcohol; and a “Western-like” characterized by a higher intake of soft drinks, red meat, fried and salted foods, fast food, and caffeine. Despite significantly higher intakes of energy, protein, carbohydrates, phosphorus, potassium, and fiber, patients following the Med-LDP exhibited lower serum phosphorus levels, calcium: phosphorus product, and PTHi concentrations.

No differences were observed in serum potassium levels. The correlation between phosphorus intake and serum phosphorus was weak and not statistically significant. The West-LDP was positively associated with serum phosphorus levels and remained an independent predictor after adjustment for potential confounders. However, after further adjustment for the prescribed dosages of phosphate binders, vitamin D supplementation and analogs, as well as calcimimetics, the association was no longer statistically significant. Conclusions: HD patients following a Med-LDP exhibited lower serum phosphorus levels despite a higher phosphorus intake.

These findings suggest that the overall dietary pattern may be a more important determinant of phosphorus homeostasis than total phosphorus intake alone.

Read the full paper

1. Introduction

Hyperphosphatemia, defined as elevated serum phosphorus concentrations, is one of the most common metabolic disturbances in patients undergoing maintenance hemodialysis (HD), affecting more than half of this population despite advances in dialysis techniques, phosphate binders, and dietary management strategies [1].

Several factors influence phosphorus homeostasis, including dietary phosphorus absorption, renal phosphate reabsorption, and the balance between bone formation and resorption [2]. As chronic kidney disease (CKD) progresses, these mechanisms become impaired, leading to vitamin D deficiency, reduced calcium absorption, and diminished renal phosphorus excretion, thereby exacerbating phosphorus and calcium imbalances. This also contributes to secondary hyperparathyroidism, stimulating bone turnover and resorption and further increasing phosphorus levels [2,3]. Consequently, hyperphosphatemia is a key component of CKD-mineral and bone disorder (CKD-MBD) and is associated with increased morbidity as it contributes to vascular calcification, bone demineralization, and cell signaling and apoptosis dysregulation, thereby increasing the risk of fractures and cardiovascular (CV) events, as well as overall and CV-related mortality [2,3].

A recent systematic review found that every 1 mg/dL increase in serum phosphorus was associated with an 18% increase in the risk of mortality [4].

The management of hyperphosphatemia is based on three fundamental pillars: dietary and lifestyle modifications, dialysis, and pharmacological treatment (including phosphate binders, active vitamin D and vitamin D analogs, and/or calcimimetics) [2]. Dietary phosphorus restriction has long been a key strategy, with older guidelines suggesting 800 to 1000 mg/day [5]. However, recent evidence suggests that phosphorus management should extend beyond total intake and consider additional nutritional factors affecting phosphorus absorption, such as the food source and matrix, the relative amounts of dietary calcium, phosphate, and vitamin D sterols, bile acid concentration, and cooking methods [5,6].

This perspective has shaped the updated KDOQI guidelines, which recommend not only adjusting dietary phosphorus intake to maintain normal serum phosphate levels but also considering the bioavailability of different phosphorus sources [5]. Animal-derived and highly processed foods containing phosphate additives have significantly higher bioavailability than plant-based sources [2,6]. Consequently, emerging literature and recent guidelines advocate reducing the consumption of ultra-processed foods with high phosphate additive content, as this may be associated with improved phosphate control [6].

There is growing recognition that assessing the overall dietary pattern may be more appropriate than focusing solely on total phosphorus intake. A Western diet: characterized by a high intake of red meat, animal fat, and highly processed foods preserved with phosphate and sodium, alongside a low intake of fresh fruits and vegetables: is estimated to provide between 1000 and 1500 mg of phosphorus per day, with 10 to 50% coming from food additives [6]. In contrast, plant-based diets may supply similar phosphorus intake, but with lower bioavailability [6,7].

These diets promote the consumption of vegetables, fruits, legumes, nuts, whole grains, and unsaturated vegetable oils while allowing the moderate consumption of animal products and limiting refined carbohydrates, sweets, and ultra-processed foods.

Furthermore, plant-based diets, including the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diets, have been associated, across diverse populations, with a reduced risk of age-related cognitive decline, dementia, Alzheimer’s disease, cardiovascular disease, and all-cause mortality [8,9,10,11,12,13].

Despite this, there is still no evidence supporting the recommendation of a specific dietary pattern to control phosphorus levels in HD patients, and few studies have focused on dietary patterns in this population. This raises a key question: could Western diets increase the risk of hyperphosphatemia, while plant-based diets: widely linked to better health outcomes: be associated with better maintenance of phosphorus balance in HD patients? Therefore, this study aimed to explore whether adopting a Mediterranean-like dietary pattern (Med-LDP), compared with a Western-like dietary pattern (West-LDP) was associated with lower serum phosphorus levels.

2. Materials and Methods

2.1. Study Design and Subjects

This was a cross-sectional, multicenter, observational study that included 564 patients undergoing maintenance HD at 37 dialysis centers in Portugal.

Patients aged ≥ 18 years who had been receiving thrice-weekly, 4 h, in-center HD using online hemodiafiltration for ≥15 months and who agreed to participate and provided written informed consent were included in the study. The minimum HD vintage of 15 months was defined considering that the Food Frequency Questionnaire (FFQ) assesses dietary habits during the 12 months preceding its administration, in addition to the usual 3-months period defined in most HD studies, which is considered as an adaptation period to treatment and dietary recommendations.

The exclusion criteria were: limited understanding of Portuguese, severe neurological or mental disorders, active neoplastic disease, major amputation (lower/upper extremities), enteral or parenteral feeding, severe alcohol or drug addiction, hepatitis C with viral replication, liver disease, and treatment with immunosuppressive agents or corticosteroids.

Among the 4600 patients undergoing HD across 37 dialysis centers, 600 patients meeting the eligibility criteria were randomly selected in equal proportions from each center. Of these, 18 patients (3%) declined to participate, resulting in a study population of 582 patients. Among the enrolled participants, 564 had available pre-dialysis serum phosphorus measurements and were therefore included in the final study population.

Patients underwent post-dilution online hemodiafiltration using high-flux polysulfone membranes (Helixone®; Fresenius Medical Care®, Bad Homburg, Germany) and ultrapure water that met the requirements of the International Organization for Standardization (ISO) 13959:2009 standard for water used in hemodialysis and related therapies.

2.2. Data Analysis

Demographic, anthropometric, body composition, biochemical parameters as well as dialysis treatment data were collected from the patients’ clinical records during the same month in which the FFQ was administered.

2.3. Anthropometric and Body Composition Analysis

Body composition was assessed using bioimpedance spectroscopy with the Body Composition Monitor (BCM) (version 3.3, Fresenius Medical Care® Deutschland GmbH, Bad Homburg, Germany) which has been validated against the gold standard reference methods in several studies involving more than 500 patients and healthy controls [14,15,16,17]. The measurements had a quality index greater than 95%. This evaluation was performed with the patient lying supine, approximately 30 min before the midweek HD sessions, with four conventional electrodes (Fresenius Medical Care): two placed on the hand and two on the foot contralateral to the vascular access.

To ensure measurement quality, only measurements with a quality indicator above 90% were accepted. This quality indicator is provided by the BCM, which performs measurements at 50 frequencies ranging from 5 to 1000 kHz. The body composition analysis included the lean tissue index (LTI), fat tissue index (FTI), body cell mass index (BCMI), fat mass (%), lean tissue mass (%), intracellular water (l), extracellular water (l), and relative overhydration (%) (pre-dialysis overhydration/extracellular water [OH/ECW]).

2.4. Dietary Intake

Dietary intake was assessed using a semi-quantitative FFQ, developed and validated for the Portuguese population [18,19]. The questionnaire was administered by a registered dietitian in a face-to-face interview while the patient was undergoing HD treatment. The FFQ included 95 food items, a section with predetermined average portion sizes, and nine intake-frequency categories ranging from “never or less than once a month” to “six or more times a day”. Patients were asked to describe their dietary habits during the previous 12 months, specifically the frequency of consumption and the mean portion size of each food item.

A booklet containing 131 color photos illustrating food servings was used as a visual aid.

Dietary intake was then estimated by multiplying the consumption frequency of each item by its respective portion size (in grams), and a seasonal factor variation factor. Information on daily intake of macro: and micronutrients was extracted from this questionnaire using Food Processor Plus software (version 11.7.217; ESHA Research, Salem, OR, USA), which contains nutritional data from the United States Department of Agriculture. The database was supplemented with information on nutrient content of Portuguese foods obtained from the Portuguese food composition table [20].

Before statistical analysis, all food items with a mean intake of ≤5 g/day were excluded using an investigator-defined operational threshold, consistent with our previously published methodology [21], to reduce the number of variables representing foods with very low average consumption in the study population.

Twenty-two food groups were created based on similar nutritional characteristics: dairy products; eggs; white meat; red meat; fish; white bread, rice, pasta and potatoes; whole grain bread; vegetables; fruit; vegetable soup; chicken soup and Portuguese green soup; legumes; nuts; olives and olive oil; oils; fried and savory snacks; fast food; bakery products; alcoholic beverages; caffeinated drinks; barley drinks; and soft drinks. Each food group was adjusted for total energy intake and used to define dietary patterns in this population. The patterns were named according to the food groups with the highest factor loadings.

2.5. Laboratory Variables

The biochemical parameters of the overall population were assessed and compared between the dietary pattern groups, including sodium, potassium, phosphorus, calcium, calcium/phosphorus product (Ca/P), intact parathyroid hormone (PTHi), normalized protein catabolic rate (nPCR), albumin, ferritin and hemoglobin. Blood samples used for biochemical analysis were collected before the midweek HD session.

Serum sodium and potassium concentrations were determined by indirect potentiometry, whereas phosphorus and calcium concentrations were assessed using the UV molybdate and o-cresolphthalein colorimetric methods, respectively. iPTH and ferritin concentrations were quantified by chemiluminescent immunoassay (CLIA). Hemoglobin was measured by spectrophotometry in whole blood, and serum albumin was determined using the bromocresol green method. All laboratory parameters were measured using identical methods across the different laboratories.

2.6. Statistical Analysis

Dietary patterns were derived from principal component analysis (PCA) based on 22 food groups. PCA with varimax rotation and Kaiser normalization was applied to improve the interpretability of the factors. The number of dietary patterns retained was determined based on eigenvalues > 1.5 (which indicate the total variance explained by a given factor), as well as the scree plot examination, and the interpretability of the derived patterns. Adherence to each dietary pattern was then determined using the factor scores generated by the PCA, and participants were assigned to the dietary pattern for which they had the highest factor score.

This approach was chosen because the aim of the study was to characterize the predominant dietary patterns within the study population and compare the clinical characteristics of participants according to their predominant dietary profile.

Data distribution was evaluated using the Kolmogorov: Smirnov test. Normally distributed continuous variables were expressed as the mean (standard deviation [SD]), whereas median (interquartile range [IQR]) was used for non-normally distributed continuous variables. Categorical variables were presented as frequencies and percentages. Pearson’s chi-squared test was used to analyze categorical variables. Differences between groups were evaluated using the independent samples t-test for normally distributed variables, and the Mann: Whitney test for non-normally distributed variables. To complement p-values, effect sizes and their 95% confidence intervals (95% CIs) were reported.

Hedges’ g was used for independent samples t-tests, Hodges: Lehmann estimates of median differences were used for the Mann: Whitney test, and odds ratios (ORs) and Cramer’s V were used for categorical variables with two and more than two categories, respectively. Confidence intervals for Cramer’s V were estimated using bias-corrected and accelerated (BCa) bootstrap methods. Spearman’s correlation tests, and linear regression analyses were performed to evaluate the associations of dietary phosphorus intake, phosphorus/protein ratio, and dietary patterns with serum phosphorus levels.

The multivariate analyses was adjusted for age, sex, presence of diabetes mellitus, energy intake, phosphorus/protein intake ratio, dialysis adequacy, HD vintage, vascular access, PTHi, albumin, residual diuresis (patient-reported), and the prescribed weekly doses of phosphorus binders (calcium acetate/magnesium carbonate, sevelamer carbonate, and sucroferric oxyhydroxide), calcimimetics (cinacalcet), and vitamin D supplementation and analogs (alfacalcidol, paricalcitol, and calcitriol). All statistical analyses were performed using the IBM SPSS Statistics software (version 29.0; IBM Corp., Armonk, NY, USA), and a p-value < 0.05 was considered statistically significant.

3. Results

Two different dietary patterns were identified (Table 1): a Med-LDP characterized by a higher intake of vegetables (109 ± 99 g/day), legumes (22 ± 30 g/day), fruit (314 ± 217 g/day), starchy products (278 ± 190 g/day), fish (69 ± 46 g/day), olive oil [14 ± 15 g/day), eggs (22 ± 23 g/day), bakery products (56 ± 72 g/day), and alcohol (95 ± 155 mL/day); and a West-LDP characterized by higher intake of soft drinks (70 ± 121 mL/day), red meat (71 ± 188 g/day), fried and savory snacks (13 ± 18 g/day), fast food (7 ± 14 g/day), and caffeinated drinks (107 ± 113 mL/day) (Table 2).

The median age of the overall population was 71 years (IQR: 61 to 78), with a median HD vintage of 65 months (IQR: 43 to 105). Male participants accounted for 41.3% of the cohort, while 31.4% had diabetes mellitus (DM). Regarding vascular access for hemodialysis, 83% of patients used arteriovenous fistulas (Table 3). Median serum phosphorus differed between the dietary patterns, with the patients following a West-LDP having higher serum phosphorus levels (Figure 1). The characteristics of the overall population, as well as differences in demographic, body composition, biochemical, and dialysis-related parameters between patients following a Med-LDP and those following a West-LDP, are presented in Table 3.

Regarding phosphate binder prescriptions, 26.6%, 3.55% and 17.38% of the overall population were prescribed calcium acetate/magnesium carbonate, sucroferric oxyhydroxide, and sevelamer carbonate, respectively. Only sevelamer carbonate prescription differed significantly between dietary patterns (p = 0.001), with 33 patients (12.04%) in the Med-LDP and 65 (22.41%) in the West-LDP group receiving this phosphate binder.

Despite the higher intakes of protein, carbohydrates, calories, fat, phosphorus, and potassium in the Med-LDP group, serum phosphorus levels, nPCR, Ca/P product, and PTHi were significantly lower (p < 0.05). Patients in the Med-LDP group also had significantly higher intakes of fiber, vitamins (A, B complex, C, D, E, K), and minerals (including calcium, iron, magnesium, manganese, phosphorus, potassium, sodium, zinc, and selenium) (Table 4). However, no statistically significant differences were observed between the two groups in serum of potassium, ferritin, hemoglobin, calcium, and sodium (p > 0.05) (Table 3).

Although a positive correlation between dietary phosphorus intake and serum phosphorus was observed in both groups, the correlation was stronger and statistically significant only in the West-LDP group (ρ = 0.171; p = 0.004), whereas it did not reach statistical significance in the Med-LDP group (ρ = 0.114; p = 0.059) (Figure 2). In contrast, the phosphorus-to-protein ratio was negatively correlated with serum phosphorus levels in both dietary patterns. The correlation was stronger and statistically significant in the Med-LDP group (ρ =: 0.167; p = 0.005), whereas it was weaker and not statistically significant in the West-LDP group (ρ =: 0.091; p = 0.120) (Figure 3).

In addition, the West-LDP was an independent predictor of higher serum phosphorus levels (p < 0.001). After adjustment for potential confounders, the West-LDP remained a predictor of higher serum phosphorus levels (p = 0.027). However, this association was no longer statistically significant after further adjustment for the prescribed doses of phosphorus binders, calcimimetics, and vitamin D supplementation and analogs (p = 0.060) (Table 5).

4. Discussion

In this study, no association between phosphorus intake and serum phosphorus levels was found. In addition, two distinct dietary patterns characterizing this population were identified: the Med-LDP (48.6%) and the West-LDP (51.4%): and the West-LDP was found to be associated with significantly higher serum phosphorus levels, independent of total phosphorus intake. In contrast, the Med-LDP, despite being richer in total phosphorus and protein, was linked to lower serum phosphorus and PTHi levels and a lower calcium: phosphorus product.

Patients following the Med-LDP tended to be older, which may reflect a stronger cultural influence of this diet among older generations, as well as greater health awareness or adherence to dietary recommendations. In contrast, the West-LDP was associated with younger age, which may reflect poorer dietary habits influenced by the dietary westernization, characterized by a higher consumption of inexpensive and ultra-processed foods rich in phosphate additives.

A higher prevalence of DM, as well as a higher age-adjusted comorbidity score was observed in the Med-LDP group. One possible explanation is that patients diagnosed with DM or other clinical conditions (such as cardiovascular diseases, dementia, cancer, etc.) [22] may be more likely to receive dietary counseling and therefore adopt healthier eating habits, including a mediterranean diet. This dietary pattern is widely promoted because of its potential benefits for glycemic control and cardiovascular health [23,24,25,26].

Regarding dietary intake, individuals following the Med-LDP demonstrated higher intakes of energy, protein, dietary fiber, and multiple micronutrients, including phosphorus and potassium. Despite these higher intakes, they exhibited lower serum phosphorus and iPTH level and lower calcium: phosphorus product, while no differences were found in serum potassium, calcium, or sodium levels. These findings suggest that patients following the Med-LDP had a more favorable biochemical profile despite their higher phosphorus and protein intake. This interpretation is further supported by Carrero J. et al. and Garagarza C. et al. [21,27], who observed that patients following a healthy plant-based diet did not have higher serum potassium levels and that greater adherence to the DASH diet was associated with lower serum potassium levels, despite the diet’s naturally higher potassium content.

This highlights the importance of the overall dietary quality rather than focusing solely on the absolute intake of single nutrients. However, our observations may also be influenced by differences in baseline clinical characteristics between the groups, including age, comorbidity burden, nutritional status, and residual kidney function. A higher proportion of patients following the Med-LDP had a residual urine output > 200 mL/day, which may have contributed to lower serum phosphorus through preserved residual phosphorus excretion. Nevertheless, residual urine output was included as a confounding factor in the multivariable analysis, and adherence to the Western-like dietary pattern remained independently associated with higher serum phosphorus levels.

In the context of dialysis, protein and energy intake should also be considered, as nutritional adequacy is essential to prevent protein: energy wasting and promote favorable outcomes. In our study, patients following the Med-LDP had higher energy and protein intakes than those adhering to a West-LDP. However, it is worth emphasizing that these intakes remained within the KDOQI-recommended ranges for energy and protein per kilogram of body weight [5]. Importantly, despite the lower nPCR and serum albumin levels observed in the Med-LDP group, both remained within the clinically recommended ranges, supporting the nutritional adequacy and safety of this dietary pattern in patients undergoing HD.

Furthermore, no differences in dialysis access or adequacy were observed, suggesting that these factors: known to influence several serum biomarkers, including serum phosphorus: were unlikely to explain the lack of a positive association with phosphorus intake.

The phosphorus-to-protein ratio was inversely associated with serum phosphorus levels in both dietary groups, with a stronger and statistically significant correlation observed in the Med-LDP (ρ = −0.167; p = 0.005). In contrast, the association was weaker and not statistically significant in the West-LDP group (ρ = −0.091; p = 0.120). Noori et al. reported that higher dietary phosphorus-to-protein ratios were associated with increased mortality risk in patients receiving maintenance HD, supporting the clinical rationale for selecting protein sources with a lower phosphorus burden per gram of protein [28,29].

However, the phosphorus-to-protein ratio does not account for differences in phosphorus bioavailability between food sources. While a lower ratio is generally considered advantageous because it identifies foods that provide less phosphorus per gram of protein, this concept assumes comparable intestinal phosphorus absorption regardless of the food source. In the Mediterranean diet, however, a substantial proportion of phosphorus is derived from plant-based foods such as legumes, nuts, and whole grains, in which phosphorus is largely bound to phytates and therefore less available for intestinal absorption.

Consequently, higher phosphorus-to-protein ratios within this dietary pattern may not necessarily result in a greater absorbed phosphorus load, potentially explaining the inverse association observed.

Interestingly, despite the higher total phosphorus intake in the Med-LDP group, serum phosphorus levels remained lower, and no significant association was observed between dietary phosphorus intake and serum phosphorus concentrations. This finding is consistent with that of Noori et al., who also reported a weak correlation between phosphorus intake and serum phosphorus levels [28]. Conversely, a significant positive correlation between dietary phosphorus intake and serum phosphorus levels was observed in the West-LDP (ρ = 0.171, p = 0.004).

Taken together, these findings suggest that the relationship between dietary phosphorus intake and serum phosphorus levels may depend not only on the quantity consumed but also on the predominant food sources of dietary phosphorus.

The contrasting associations observed between the dietary patterns further support the concept that the clinical interpretation of the phosphorus-to-protein ratio should consider the overall dietary pattern. Since dietary patterns capture the combined effects of multiple foods and nutrients rather than isolated dietary components, the inverse correlation observed in the Med-LDP group may be related to the overall dietary matrix.

As emphasized by St-Jules et al. and Byrne et al., dietary phosphorus management in CKD should consider not only the phosphorus-to-protein ratio but also the phosphorus source, bioavailability, phosphate additives, and the broader food matrix [30,31]. This is particularly relevant to Western dietary patterns, in which processed and ultra-processed foods contribute substantially to phosphorus intake through highly bioavailable phosphate additives. In fact, phosphate additive intake potentially accounts for between 10% and 50% of total phosphorus intake.

These additives are widely used in processed and ultra-processed foods, including processed meats, fast food, bakery products, and soft drinks, particularly cola beverages, thereby increasing the intake of highly bioavailable phosphorus, which may not be fully captured by conventional dietary assessment methods [6,29].

The West-LDP was also found to be an independent predictor of higher serum phosphorus levels. Overall, these findings suggest that dietary patterns may be a more relevant determinant of serum phosphorus levels than either total phosphorus intake or the phosphorus-to-protein ratio considered in isolation This association may be partly explained by differences in food sources and phosphorus bioavailability. This challenges the traditional phosphorus-restriction model, which often discourages the consumption of nutrient-dense, phosphorus-rich foods such as legumes and whole grains, and instead supports a more nuanced approach that prioritizes food quality, bioavailability, and the overall dietary context.

Accordingly, current guidelines emphasize the individualization of dietary management rather than rigid phosphorus restriction [5]. However, this predictive effect was lost when the model was adjusted for the prescribed dose of phosphorus binders, calcimimetics, and vitamin D supplements and analogs. This may reflect a greater influence of these agents on control serum phosphorus in the context of diets with a high phosphorus content.

Nevertheless, from a clinical perspective, dietary counseling, as one of the cornerstone approaches to control hyperphosphatemia and CKD-MBD in HD patients [2], should extend beyond phosphorus counting and focus on educating patients about phosphorus sources and dietary patterns that may support mineral balance while maintaining nutritional adequacy, as previously demonstrated by Fornasari et al. and Sullivan et al. [32,33]. Further studies are warranted to examine the long-term effects of phosphorus quality and the phosphorus-to-protein ratios on mineral metabolism and health outcomes.

The cross-sectional design of this study can be considered as a limitation because it does not allow causal relationships to be established. The use of a food frequency questionnaire is subject to recall bias and may lead to errors in the estimation of dietary intake. The dietary patterns identified in this study were empirically derived using PCA in a Portuguese cohort and do not represent validated measures of adherence to the Mediterranean or Western diets. Furthermore, the phosphorus content of foods, especially processed foods, can be highly variable and is not consistently documented in nutrient databases, potentially leading to the underestimation or overestimation of intake.

The strengths of this study include its large multicenter sample comprising 564 HD patients from 37 dialysis units which increased the statistical power and supports the generalizability of the findings. Furthermore, the study simultaneously evaluated dietary intake, dietary patterns, mineral metabolism biomarkers, nutritional parameters, and dialysis-related variables, allowing for a comprehensive assessment of phosphorus homeostasis. This included the evaluation of total phosphorus intake, the phosphorus-to-protein ratio, and dietary patterns, providing a broader assessment of dietary phosphorus than would be achieved by assessing isolated nutrients alone.

By adopting a dietary pattern approach that reflects real-world eating behaviors, this study provides clinically relevant insights that are aligned with current guideline recommendations and may enhance the translational value of the findings in routine clinical practice.

5. Conclusions

In patients undergoing HD, a Mediterranean-like dietary pattern was associated with lower serum phosphorus concentrations despite a higher phosphorus intake. Additionally, this dietary pattern was not linked to increased serum potassium, and patients following this dietary pattern were able to meet the recommended protein and energy intake targets. In contrast, the Western-like dietary pattern was associated with higher serum phosphorus concentrations, although this association was no longer statistically significant after adjustment for pharmacological treatments that may impact serum phosphorus levels.

These findings support individualized dietary counseling that emphasizes phosphorus quality and overall dietary patterns rather than phosphorus restriction alone, while preserving nutritional adequacy. Further longitudinal studies are needed to evaluate the long-term impact of dietary patterns, plant-based protein intake and phosphorus bioavailability on mineral metabolism and clinical outcomes in HD patients.

Future longitudinal or interventional studies should assess the causal relationships between dietary patterns and phosphorus metabolism, considering not only phosphorus intake but also its absorption, excretion, and the use of phosphate binders. Additionally, research should explore the socioeconomic, behavioral, and educational factors that influence the adoption of healthier dietary patterns. More precise measurement tools, including phosphorus bioavailability indices and biomarkers of dietary intake, could further refine our understanding of the relationship between diet and phosphorus metabolism in patients with CKD.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Author Contributions

Conceptualization, A.V., I.P.N., J.J. and C.G.; methodology, A.V., I.P.N., J.J. and C.G.; software, J.J.; formal analysis, A.V., I.P.N. and J.J.; investigation, A.V., I.P.N. and J.J.; resources, A.V., I.P.N., J.J. and C.G.; data curation, A.V., I.P.N., J.J. and C.G.; writing: original draft preparation, A.V., I.P.N. and J.J.; writing: review and editing, C.G. and A.F.; visualization, A.V., I.P.N. and J.J.; supervision, C.G. and A.F. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved on the 20 April 2018, by the Ethics Committee of Fresenius Medical Care, Portugal in accordance with and for the purposes set out in the Portuguese Law No. 21/2004, of April 16 which issues a formal decision letter instead of assigning a numerical or alphanumeric codes to approved studies.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data underlying this article cannot be shared publicly due to patient confidentiality and ethical and privacy restrictions.

Conflicts of Interest

The authors are employees of Nephrocare Portugal.

Abbreviations

The following abbreviations are used in this manuscript: HDHemodialysisCKDChronic Kidney diseaseCKD-MBDCKD-Mineral Bone DiseaseCVCardiovascular eventsBCMBody Composition MonitorLTILean Tissue IndexFTIFat Tissue IndexBCMIBody Cell Mass IndexOH/ECWOverhydration/extracellular water pre-dialysisCa/PCalcium/phosphorus productPTHiIntact parathyroid hormonenPCRnormalized Protein Catabolic RatePCAPrincipal Component AnalysisSDStandard DeviationIQRInterquartile rangeDMDiabetes MellitusMed-LDPMediterranean-like dietary patternWest-LDPWestern-like dietary pattern

References

1. Blayney M.J. Tentori F. Trends and Consequences of Mineral Bone Disorder in Haemodialysis Patients: Lessons from the Dialysis Outcomes and Practice Patterns Study (DOPPS) J. Ren. Care 2009 35 7 13 10.1111/j.1755-6686.2009.00048.x 19222725
2. Rastogi A. Bhatt N. Rossetti S. Beto J. Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm J. Ren. Nutr. 2021 31 21 34 10.1053/j.jrn.2020.02.003 32386937
3. Yamada S. Nakano T. Role of Chronic Kidney Disease (CKD): Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD J. Atheroscler. Thromb. 2023 30 835 850 10.5551/jat.RV22006 37258233 PMC10406631
4. Palmer S.C. Hayen A. Macaskill P. Pellegrini F. Craig J.C. Elder G.J. Strippoli G.F.M. Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals with Chronic Kidney Disease a Systematic Review and Meta-Analysis JAMA 2011 305 1119 1127 10.1001/jama.2011.308 21406649
5. Ikizler T.A. Burrowes J.D. Byham-Gray L.D. Campbell K.L. Carrero J.J. Chan W. Fouque D. Friedman A.N. Ghaddar S. Goldstein-Fuchs D.J. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update Am. J. Kidney Dis. 2020 76 S1 S107 10.1053/j.ajkd.2020.05.006 32829751
6. Vervloet M.G. van Ballegooijen A.J. Prevention and Treatment of Hyperphosphatemia in Chronic Kidney Disease Kidney Int. 2018 93 1060 1072 10.1016/j.kint.2017.11.036 29580635
7. Garagarza C. Valente A. Caetano C. Ramos I. Sebastião J. Pinto M. Oliveira T. Ferreira A. Guerreiro C.S. Mediterranean Diet: A Dietary Pattern Related to Nutritional Benefits for Hemodialysis Patients J. Ren. Nutr. 2023 33 472 481 10.1053/j.jrn.2023.01.006 36731683
8. Dominguez L.J. Veronese N. Baiamonte E. Guarrera M. Parisi A. Ruffolo C. Tagliaferri F. Barbagallo M. Healthy Aging and Dietary Patterns Nutrients 2022 14 889 10.3390/nu14040889 35215539 PMC8879056
9. English L.K. Ard J.D. Bailey R.L. Bates M. Bazzano L.A. Boushey C.J. Brown C. Butera G. Callahan E.H. de Jesus J. Evaluation of Dietary Patterns and All-Cause Mortality A Systematic Review JAMA Netw. Open 2021 4 e2122277 10.1001/jamanetworkopen.2021.22277 34463743 PMC8408672
10. Obbagy J. Essery E. Dietary Patterns and Risk of Cardiovascular Disease: A Systematic Review 2020 Dietary Guidelines Advisory Committee, Dietary Patterns SubcommitteeNutrition Evidence Systematic Review, Center for Nutrition Policy and Promotion, Food and Nutrition ServiceAlexandria, VA, USA2020
11. Wang W. Liu Y. Li Y. Luo B. Lin Z. Chen K. Liu Y. Dietary Patterns and Cardiometabolic Health: Clinical Evidence and Mechanism MedComm 2023 4 e212 10.1002/mco2.212 36776765 PMC9899878
12. Ellouze I. Sheffler J. Nagpal R. Arjmandi B. Dietary Patterns and Alzheimer’s Disease: An Updated Review Linking Nutrition to Neuroscience Nutrients 2023 15 3204 10.3390/nu15143204 37513622 PMC10384681
13. Booth S. Talegawkar S. Fung T. Hoelscher D.M. Anderson C.A.M. Deierlein A. Gardner C. Giovannucci E. Raynor H. Stanford F.C. Dietary Patterns and Risk of Cognitive Decline, Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment: A Systematic Review USDA Nutrition Evidence Systematic ReviewAlexandria, VA, USA2024 10.52570/NESR.DGAC2025.SR20 39908392
14. Marcelli D. Usvyat L.A. Kotanko P. Bayh I. Canaud B. Etter M. Gatti E. Grassmann A. Wang Y. Marelli C. Body Composition and Survival in Dialysis Patients: Results from an International Cohort Study Clin. J. Am. Soc. Nephrol. 2015 10 1192 1200 10.2215/CJN.08550814 25901091 PMC4491292
15. Duarte M.P. Martins P. Leal D.V. Nóbrega O.T. Ribeiro H.S. Viana J.L. Association of Diabetes with Sarcopenia in Patients on Hemodialysis: A Nationwide Cross-Sectional Study in Portugal Clin. Nutr. ESPEN 2025 70 297 302 10.1016/j.clnesp.2025.09.023 41022178
16. Wabel P. Chamney P. Moissl U. Jirka T. Importance of Whole-Body Bioimpedance Spectroscopy for the Management of Fluid Balance Blood Purif. 2009 27 75 80 10.1159/000167013 19169022 PMC2813803
17. Onofriescu M. Siriopol D. Voroneanu L. Hogas S. Nistor I. Apetrii M. Florea L. Veisa G. Mititiuc I. Kanbay M. Overhydration, Cardiac Function and Survival in Hemodialysis Patients PLoS ONE 2015 10 e0135691 10.1371/journal.pone.0135691 26274811 PMC4537261
18. Lopes C.M.D.M. Reprodutibilidade e Validação de Um Questionário Semiquantitativo de Frequência Alimentar Alimentação e Enfarte Agudo Do Miocárdio; Estudo Caso-Controlo de Base Comunitária Dissertacão de DoutoramentoUniversidade de LisboaLisbon, Portugal2000
19. Lopes C. Aro A. Azevedo A. Ramos E. Barros H. Intake and Adipose Tissue Composition of Fatty Acids and Risk of Myocardial Infarction in a Male Portuguese Community Sample J. Am. Diet. Assoc. 2007 107 276 286 10.1016/j.jada.2006.11.008 17258965
20. Ferreira F. Graça M. Tabela de Composição de Alimentos Portugueses 2nd ed. Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA) Editorial do Ministério da Educação Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA), Editorial do Ministério da EducaçãoLisbon, Portugal1985
21. Garagarza C. Valente A. Caetano C. Ramos I. Sebastião J. Pinto M. Oliveira T. Ferreira A. Guerreiro C.S. Potassium Intake: (Un)Expected Non-Predictor of Higher Serum Potassium Levels in Hemodialysis Dash Diet Consumers Nutrients 2022 14 2071 10.3390/nu14102071 35631212 PMC9146185
22. Zhou S. Zhang X.H. Zhang Y. Gong G. Yang X. Wan W.H. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients Cancer Manag. Res. 2022 14 1683 1691 10.2147/CMAR.S361495 35573259 PMC9091471
23. Wu M.J. Hung C.H. Yong S.B. Ching G.S. Hsu H.J. Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials Nutrients 2025 17 3908 10.3390/nu17243908 41470853 PMC12735701
24. Esposito K. Maiorino M.I. Bellastella G. Chiodini P. Panagiotakos D. Giugliano D. A Journey into a Mediterranean Diet and Type 2 Diabetes: A Systematic Review with Meta-Analyses BMJ Open 2015 5 e008222 10.1136/bmjopen-2015-008222 26260349 PMC4538272
25. Salas-Salvadó J. Díaz-López A. Ruiz-Canela M. Basora J. Fitó M. Corella D. Serra-Majem L. Wärnberg J. Romaguera D. Estruch R. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial Diabetes Care 2019 42 777 788 10.2337/dc18-0836 30389673
26. Jing T. Zhang S. Bai M. Chen Z. Gao S. Li S. Zhang J. Effect of Dietary Approaches on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review with Network Meta-Analysis of Randomized Trials Nutrients 2023 15 3156 10.3390/nu15143156 37513574 PMC10384204
27. Carrero J.J. González-Ortiz A. Avesani C.M. Bakker S.J.L. Bellizzi V. Chauveau P. Clase C.M. Cupisti A. Espinosa-Cuevas A. Molina P. Plant-Based Diets to Manage the Risks and Complications of Chronic Kidney Disease Nat. Rev. Nephrol. 2020 16 525 542 10.1038/s41581-020-0297-2 32528189
28. Noori N. Kalantar-Zadeh K. Kovesdy C.P. Bross R. Benner D. Kopple J.D. Association of Dietary Phosphorus Intake and Phosphorus to Protein Ratio with Mortality in Hemodialysis Patients Clin. J. Am. Soc. Nephrol. 2010 5 683 692 10.2215/CJN.08601209 20185606 PMC2849686
29. Watanabe M.T. Araujo R.M. Vogt B.P. Barretti P. Caramori J.C.T. Most Consumed Processed Foods by Patients on Hemodialysis: Alert for Phosphate-Containing Additives and the Phosphate-to-Protein Ratio Clin. Nutr. ESPEN 2016 14 37 41 10.1016/j.clnesp.2016.05.001 28531397
30. Byrne F.N. Gillman B. Kiely M. Bowles M. Connolly P. Earlie J. Murphy J. Rennick T. Reilly E.O. Shiely F. Revising Dietary Phosphorus Advice in Chronic Kidney Disease G3-5D J. Ren. Nutr. 2021 31 132 143 10.1053/j.jrn.2020.04.003 32586712
31. St-Jules D.E. Woolf K. Pompeii M.-L. Kalantar-Zadeh K. Sevick M.A. Re-Examining the Phosphorus-Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status? J. Ren. Nutr. 2016 26 136 140 10.1053/j.jrn.2015.12.004 26873260 PMC5986175
32. de Fornasari M.L.L. dos Santos Sens Y.A. Replacing Phosphorus-Containing Food Additives with Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial J. Ren. Nutr. 2017 27 97 105 10.1053/j.jrn.2016.08.009 27751628
33. Sullivan C. Sayre S.S. Leon J.B. Machekano R. Love T.E. Porter D. Marbury M. Sehgal A.R. Effect of Food Additives on Hyperphosphatemia among Patients with End-Stage Renal Disease: A Randomized Controlled Trial JAMA 2009 301 629 635 10.1001/jama.2009.96 19211470
Figure 1

Distribution of serum phosphorus concentrations according to dietary pattern.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 2

Correlation between serum phosphorus and dietary phosphorus intake, according to study group. (a) Med-LDP: ρ = 0.114, p = 0.059. (b) West-LDP: ρ = 0.0171, p = 0.004.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 3

Correlation between serum phosphorus and dietary phosphorus/protein ratio, according to study group. (a) Med-LDP: ρ = −0.167, p = 0.005. (b) West-LDP: ρ = −0.091, p = 0.120.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Factor loadings for two dietary patterns derived by Principal Components Analysis. Data expressed as factor loading (correlation coefficient between each food group and dietary pattern). Food groups with factor loadings ≥ 0.3 were bolded to indicate the main food groups in each component.

Food GroupsComponents
Med-LDPWest-LDP
Dairy products0.2360.008
White meat0.2770.206
Red meat0.224 0.538
Olives and olive oil 0.399 0.328
Oils0.1440.241
White bread, rice, pasta and potatoes 0.316 0.136
Eggs 0.353 0.164
Fried and savory snacks0.260 0.555
Bakery products 0.328 0.272
Alcoholic beverages 0.388 0.064
Caffeinated drinks0.062 0.358
Fast food0.017 0.686
Vegetable soup0.237−0.261
Chicken soup and Portuguese green soup0.188−0.094
Barley drinks0.221−0.171
Vegetables 0.649 0.112
Fruit 0.630 −0.001
Whole grain bread0.051−0.126
Soft drinks−0.060 0.697
Legumes 0.550 0.100
Nuts0.0420.151
Fish 0.578 0.016
Table 2

Food consumption according to the dietary pattern.

CharacteristicsMed-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size
(95% CI)
p
Dairy products (g/day) 1250 ± 229174 ± 1760.375 (0.208 to 0.541) 2<0.001
White meat (g/day) 138 ± 3633 ± 300.149 (−0.016 to 0.314) 20.077
Red meat (g/day) 155 ± 6871 ± 188−0.115 (−0.279 to 0.051) 20.165
Fish (g/day) 169 ± 4641 ± 290.712 (0.541 to 0.881) 2<0.001
Eggs (g/day) 122 ± 2315 ± 170.333 (0.167 to 0.499) 2<0.001
Olives and olive oil (g/day) 114 ± 1510 ± 130.242 (0.076 to 0.407) 20.004
Oils (g/day) 15 ± 66 ± 7−0.084 (−0.249 to 0.081) 20.318
White bread, rice, pasta and potatoes (g/day) 1278 ± 190235 ± 1320.260 (0.094 to 0.426) 20.002
Whole grain bread (g/day) 186 ± 11461 ± 880.244 (0.078 to 0.409) 20.004
Vegetables (g/day) 1109 ± 9961 ± 590.589 (0.420 to 0.757) 2<0.001
Fruit (g/day) 1314 ± 217168 ± 1070.850 (0.677 to 1.022) 2<0.001
Legumes (g/day) 122 ± 3012 ± 160.431 (0.264 to 0.598) 2<0.001
Nuts (g/day) 12 ± 63 ± 1−0.074 (−0.239 to 0.091) 20.380
Vegetable soup (mL/day) 1150 ± 16648 ± 690.810 (0.638 to 0.981) 2<0.001
Chicken soup and Portuguese green soup (mL/day) 18 ± 262 ± 100.318 (0.152 to 0.484) 2<0.001
Fried and savory snacks (g/day) 111 ± 1513 ± 18−0.102 (−267 to 0.063) 20.224
Bakery products (g/day) 156 ± 7252 ± 520.062 (−0.103 to 0.227) 20.459
Alcoholic beverages (mL/day) 195 ± 15552 ± 1160.315 (0.149 to 0.480) 2<0.001
Caffeinated drinks (mL/day) 187 ± 83107 ± 113−0.196 (−0.361: (−0.0311)) 20.020
Barley drinks (mL/day) 147 ± 1165 ± 250.511 (0.343 to 0.679) 2<0.001
Soft drinks (mL/day) 118 ± 4170 ± 121−0.575 (−0.743: (−0.406)) 2<0.001
Fast Food (g/day) 12 ± 47 ± 14−0.442 (−0.609: (−0.275)) 2<0.001

1 Mean ± Standard Deviation; 2 Hodges: Lehmann differences and 95% CI.

Table 3

Patients’ characteristics according to the dietary pattern.

CharacteristicsOverall
(n = 564)
Med-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size (95% CI) p
Demographics
Age (years) 271 (61 to 78)73 (65 to 80)69 (54 to 76)5 (3 to 7) 3<0.001
Male (%)233 (41.3%)107 (39.1%)126 (43.4%)0.834 (0.596 to 1.167) 40.289
Diabetes mellitus (%)177 (31.4%)100 (36.5%)77 (26.6%)1.590 (1.111 to 2.275) 40.011
Age-Adjusted Charlson Index (score)6 (4 to 7)6 (5 to 8)5 (4 to 7)1 (1 to 1) 3<0.001
Dialysis characteristics
Hemodialysis vintage (months) 265 (43 to 104.8)62 (41 to 99)69 (43 to 112)−6 (−12 to 0) 30.034
Arteriovenous fistula (%)468 (83.0%)229 (83.6%)239 (82.4%)0.058 (0.003 to 0.183) 50.392
Catheter (%)36 (6.4%)20 (7.3%)16 (5.5%)
Arteriovenous grafts (%)60 (10.6%)25 (9.1%)35 (12.1%)
Kt/V: dialysis adequacy 21.70 (1.50 to 1.90)1.70 (1.49 to 1.92)1.71 (1.52 to 1.87)0.01(−0.06 to 0.07) 30.884
OH/ECW pre (%) 27.3 (2.7 to 11.88)7.5 (3.2 to 11.9)7.1 (2.2 to 11.7)0.7 (−0.6 to 1.9) 30.317
Intracellular water (L) 117.37 ± 3.7916.99 ± 3.6217.72 ± 3.91−0192 (−0.366: (−0.018)) 60.031
Extracellular water (L) 216.3 (14.5 to 18.3)16.3 (14.6 to 18.6)16.0 (14.4 to 18.2)−0.2 (−0.3 to 0) 30.321
Intradialytic weight gain (%) 23.1 (2.3 to 4.0)2.9 (2.2 to 4.0)3.3 (2.3 to 4.2)−0.2 (−0.4 to 0) 30.079
Residual diuresis > 200 mL (%)333 (59.3%)175 (64.3%)158 (54.5%)1.507 (1.074 to 2.116) 40.017
Body Composition
BMI (kg/m2) 225.8 (22.6 to 29.0)26.0 (23.2 to 29.8)25.4 (22.3 to 28.8)0.71 (−0.08 to 1.5) 30.079
Lean Tissue Mass (%) 246.9 (38.7 to 56.1)45.4 (37.6 to 52.9)49.3 (40.8 to 60.1)−4.2 (−6.6: (−1.9)) 3<0.001
Lean Tissue Index (kg/m2) 212.2 (10.7 to 14.2)12 (10.4 to 13.5)12.6 (10.9 to 14.5)−0.7 (−1.1: (−0.2)) 30.005
Body Cell Mass Index (kg/m2) 210.7 (8.8 to 13.2)10.2 (8.3 to 12.4)11.2 (9.0 to 13.8)−0.831 (−1.421: (−0.257)) 30.005
Fat Mass (%) 236.8 (29.8 to 42.9)37.6 (32.9 to 43.5)35.2 (27.5 to 41.6)2.8 (1.1 to 4.6) 30.001
Fat Tissue Index (kg/m2) 213.0 (9.4 to 16.9)13.9 (10.7 to 17.2)12.2 (8.4 to 16.3)1.5 (0.5 to 2.4) 30.003
Biochemical Parameters
nPCR (g/kg/day) 21.1 (1.0 to 1.3)1.1 (1.0 to 1.3)1.2 (1.1 to 1.3)−0.07 (−0.120: (−0.020)) 30.008
Sodium (mEq/L) 2139 (138 to 141)139 (137 to 141)140 (138 to 141)0 (−1.0 to 0) 30.061
Potassium (mEq/L) 15.3 ± 0.75.3 ± 0.75.3 ± 0.7−0.025 (−0.193 to 0.143) 60.948
Phosphorus (mg/dL) 24.2 (3.5 to 5.0)3.9 (3.3 to 4.8)4.4 (3.6 to 5.2)−0.4 (−0.6: (−0.2)) 3<0.001
Calcium (mg/dL) 28.9 (8.5 to 9.4)8.9 (8.6 to 9.3)8.9 (8.5 to 9.5)0 (−0.1 to 0.1) 30.925
Calcium/Phosphorus product [(mg/dL)2] 237.3 (30.7 to 46.1)35.0 (29.2 to 44.9)39.4 (32.7 to 47.1)−3.43 (−5.24: (−1.62)) 3<0.001
PTHi (ng/L) 2352 (211 to 573)297 (183 to 496)399 (232 to 618.5)−80 (−122: (−38)) 3<0.001
Albumin (g/dL) 24.05 (3.9 to 4.2)4 (3.8 to 4.2)4.1 (3.9 to 4.3)−0.1 (−0.13: (−0.03)) 3<0.001
Ferritin (µg/L) 2455 (329 to 611)455(328 to 620)455 (329 to 602)1.1 (−35.9 to 37.8) 30.957
Hemoglobin (g/dL) 211.2 (10.6 to 11.9)11.2 (10.7 to 11.9)11.2 (10.6 to 11.8)0.1 (−0.1 to 0.2) 30.342
Phosphorus Binders
weekly prescription (mg)
Calcium acetate/magnesium 12801 ± 59572491 ± 55743093 ± 6293−0.101 (−0.266 to 0.100) 60.232
Sevelamer carbonate 12636 ± 72411574 ± 50433640 ± 8720−0.288 (−0.453: (−0.122)) 6<0.001
Sucroferric oxyhydroxide 1183 ± 1274141 ± 1171223 ± 13660.065 (−0.453: (−0.122)) 60.442

1 Mean ± SD; 2 Median (IQR); 3 Hedges’ g and 95% CI; 4 Odds Ratio and 95% CI; 5 Cramer’s V and 95% CI; 6 Hodges: Lehmann differences and 95% CI; TEI: Total Energy Intake.

Table 4

Patients’ dietary intake according to the dietary pattern.

CharacteristicsOverall (n = 564)Med-LDP
(n = 274)
West-LDP
(n = 290)
Effect Size (95% CI) p
Energy (kcal) 11808 (1449 to 2298)2025 (1654 to 2515)1618 (1285 to 2032)407 (304 to 509) 2<0.001
Energy (kcal/kg) 126.4 (20.4 to 33.5)29.2 (23.3 to 36.6)24.1 (17.1 to 30.3)5.45 (3.838 to 7.060) 2<0.001
Protein (g) 175.4 (58.6 to 98.8)84.4 (68.3 to 107.8)68.2 (50.0 to 87.4)18.086 (13.528 to 22.520) 2<0.001
Protein (g/kg) 11.1 (0.9 to 1.4)1.2 (1.0 to 1.6)1.0 (0.7 to 1.3)0.240 (0.173 to 0.309) 2<0.001
Carbohydrates (g) 1240 (184 to 294)266 (222 to 331)213 (169 to 266)54.986 (41.552 to 68.505) 2<0.001
Complex carbohydrates (g) 174.5 (56.9 to 104.8)83.0 (63.7 to 115.8)66.6 (51.6 to 95.1)15.421 (10.225 to 20.841) 2<0.001
Sugar (g) 169.3 (50.1 to 95.0)77.3 (62.1 to 110.1)60.4 (43.9 to 83.8)19.751 (14.616 to 24.722) 2<0.001
Total fat (g) 157.1 (44.1 to 77.6)63.4 (49.4 to 81.1)50.3 (40.1 to 71.0)10.609 (6.937 to 14.308) 2<0.001
Saturated fat (g) 117.4 (13.2 to 24.0)19.0 (14.7 to 25.0)15.6 (12.5 to 23.3)2.501 (1.271 to 3.737) 2<0.001
Monounsaturated fat (g) 124.7 (18.8 to 34.0)27.8 (21.6 to 35.4)21.7 (17.0 to 30.4)4.983 (3.371 to 6.629) 2<0.001
Polyunsaturated fat (g) 19.6 (7.2 to 12.5)10.6 (8.3 to 13.4)8.4 (6.5 to 11.3)1.831 (1.231 to 2.431) 2<0.001
Cholesterol (mg) 1243 (161 to 332)280 (199 to 348)208 (142 to 281)59.724 (40.996 to 78.497) 2<0.001
Protein (% TEI) 116.7 (15.3 to 18.7)16.8 (15.3 to 18.7)16.6 (15.3 to 18.7)0.154 (−0.272 to 0.583) 20.479
Carbohydrates (% TEI) 153.1 (47.7 to 57.0)53.4 (48.6 to 57.0)52.8 (46.7 to 57.0)0.400 (−0.792 to 1.600) 20.529
Fat (% TEI) 129.2 (25.7 to 32.6)28.5 (25.3 to 32.0)30 (26.2 to 33.8)−1.328 (−2.232: (−0.434)) 20.003
Dietary fiber (g) 119.1 (14.4 to 25.9)23.2 (18.1 to 30.2)16.0 (12.4 to 20.9)7.081 (5.856 to 8.363) 2<0.001
Caffeine (mg) 158.4 (25.7 to 81.3)38 (16.0 to 79.8)78.8 (31.5 to 85.9)−9.502 (−16.312: (−2.461)) 2<0.001
Vitamin B6 (mg) 11.4 (1.0 to 1.7)1.5 (1.3 to 1.9)1.1 (0.9 to 1.5)0.416 (0.339 to 0.495) 2<0.001
Vitamin B12 (µg) 15.0 (3.3 to 7.4)6.0 (3.8 to 8.1)4.2 (2.7 to 6.6)1.473 (0.997 to 1.964) 2<0.001
Folate (µg) 1206 (156 to 275)239 (191 to 317)178 (136 to 233)67.744 (51.328 to 78.667) 2<0.001
Vitamin C (mg) 165.2 (45.3 to 98.2)81.8 (58.7 to 117.06)52.5 (36.7 to 76.4)29.386 (23.892 to 35.271) 2<0.001
Vitamin D (µg) 12.5 (1.8 to 3.6)2.9 (2.0 to 4.2)2.2 (1.5 to 3.1)0.695 (0.489 to 0.905) 2<0.001
Calcium (mg) 1666 (461 to 894)769 (557 to 1024)555 (395 to 784)196.130 (145.102 to 249.273) 2<0.001
Iron (mg) 113.3 (10.7 to 16.6)14.7 (12.2 to 18.8)12.0 (9.4 to 15.0)3.044 (2.277 to 3.809) 2<0.001
Magnesium (mg) 1243 (191 to 322)287 (227 to 366)212 (161 to 268)78.334 (60.749 to 90.256) 2<0.001
Phosphorus (mg) 11068 (814 to 1385)1206 (941 to 1559)954 (701 to 1213)278.921 (211.719 to 346.389) 2<0.001
Phosphorus/protein ratio (mg/g) 114.0 (12.7 to 15.4)14.3 (12.8 to 15.6)13.7 (12.5 to 15.3)0.433 (0.102 to 0.751) 20.010
Potassium (mg) 12320 (1791 to 2946)2661 (2218 to 3352)1970(1481 to 2462)762.992 (630.765 to 892.511) 2<0.001
Selenium (µg) 191.3 (67.8 to 139.7)108.2 (79.1 to 158.6)78.8 (62.1 to 116.4)26.906 (19.728 to 34.289) 2<0.001
Sodium (mg) 12196 (1634 to 2825)2456 (1837 to 2998)1972 (1464 to 2534)448.257 (312.820 to 583.106) 2<0.001
Zinc (mg) 18.8 (6.7 to 11.6)9.9 (7.6 to 13.1)7.9 (5.8 to 10.4)2.055 (1.499 to 2.591) 2<0.001

1 Median (IQR); 2 Hodges: Lehmann differences and 95% CI; TEI: Total Energy Intake.

Table 5

Linear Regression Analysis Between Serum Phosphorus and Dietary Pattern.

Dependent VariableIndependent VariableB (95% CI)
(n = 564)
p B a (95% CI)
(n = 355)
p B b (95% CI)
(n = 352)
p
Serum phosphorusDietary Pattern (West-LDP;
Indicator: Med-LDP)
0.35 (0.16 to 0.54)<0.0010.29 (0.03 to 0.54)0.0270.24 (−0.01 to 0.49)0.060

a Adjusted for: age, gender, DM, dialysis vintage, PTHi, dialysis dose (Kt/V), pre-dialysis albumin, energy (kcal), phosphorus/protein ratio, vascular access, residual diuresis > 200 mL. b Adjusted for: age, gender, DM, dialysis vintage, PTHi, dialysis dose (Kt/V), pre-dialysis albumin, energy (kcal), phosphorus/protein ratio, vascular access, residual diuresis > 200 mL, weekly prescription of phosphorus binders, calcimimetics, and vitamin D supplementation and analogs.

Publication and source details

Original title: Mediterranean-like Dietary Pattern and Serum Phosphorus in Hemodialysis: Beyond Food Phosphorus Content

Ana Valente; Inês Pastor Neto; Joana Jesus; Cristina Garagarza; Aníbal Ferreira

Nutrients · 2026

* Correspondence: cgaragarza@gmail.com© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:45:08.349988+00:00

DOI: 10.3390/nu18172877 · PMC13567454